Hospital da Senhora da Oliveira Guimarães

Futó vizsgálatok

• Toboroz

  Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer

  NCT06731478· 3. fázis· Daiichi Sankyo· Forrás

• Toboroz

  Efficacy and safety study of frexalimab (SAR441344) in adults with relapsing forms of multiple sclerosis

  2023-504358-36-00· 3. fázis· Sanofi-Aventis Recherche & Developpement· Forrás

• Fut, nem toboroz

  A Research Study to Look at Long-term Treatment With a Medicine Called NNC6019-0001 for People Who Have Heart Failure Due to Transthyretin Amyloidosis

  NCT06260709· 2. fázis· Novo Nordisk A/S· Forrás

• Fut, nem toboroz

  Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Patients With Hormone Receptor-positive/Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Metastatic Breast Cancer Who Have Received Endocrine Therapy

  NCT05840211· 3. fázis· Gilead Sciences· Forrás

• Meghívásos bevonás

  An Open-label Study of XEN1101 in Epilepsy

  NCT05718817· 3. fázis· Xenon Pharmaceuticals Inc.· Forrás

• Fut, nem toboroz

  The PORTuguese Registry of Supera Supported Femoral-Fopliteal Revascularization (SupPORT Registry)

  NCT06416644· Hospital do Divino Espírito Santo de Ponta Delgada· Forrás

• Toboroz

  A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures

  NCT05667142· 3. fázis· Xenon Pharmaceuticals Inc.· Forrás

• Fut, nem toboroz

  ABTECT - Maintenance

  NCT05535946· 3. fázis· Abivax S.A.· Forrás

• Meghívásos bevonás

  An Extension Study to Assess Long-Term Safety of Eplontersen in Adults With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)

  NCT05667493· 3. fázis· Ionis Pharmaceuticals, Inc.· Forrás

• Fut, nem toboroz

  A Study of Zanidatamab in Combination With Chemotherapy Plus or Minus Tislelizumab in Patients With HER2-positive Advanced or Metastatic Gastric and Esophageal Cancers

  NCT05152147· 3. fázis· Jazz Pharmaceuticals· Forrás

• Fut, nem toboroz

  A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( NATiV3 )

  NCT04849728· 3. fázis· Inventiva Pharma· Forrás

• Fut, nem toboroz

  Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH)

  NCT04822181· 3. fázis· Novo Nordisk A/S· Forrás

• Fut, nem toboroz

  A Comparative Study of AZD9833 Plus Palbociclib Versus Anastrozole Plus Palbociclib in Patients With ER-Positive HER2 Negative Breast Cancer Who Have Not Received Any Systemic Treatment for Advanced Disease

  NCT04711252· 3. fázis· AstraZeneca· Forrás

• Fut, nem toboroz

  Personalized Therapy Study - HFRS (TriageHF) Post Approval Study

  NCT04489225· Medtronic· Forrás

• Fut, nem toboroz

  Personalized Therapy Study - Intrinsic Antitachycardia Pacing Post-Approval Study (iATP PAS)

  NCT04496518· Medtronic· Forrás

• Fut, nem toboroz

  A Research Study to Look at How Semaglutide Compared to Placebo Affects Diabetic Eye Disease in People With Type 2 Diabetes

  NCT03811561· 3. fázis· Novo Nordisk A/S· Forrás

• Fut, nem toboroz

  Clinical trial to compare the efficacy of two treatment sequencing schemes with chemotherapy (the regime called FOLFOX and FOLFIRI) in combination with biologic drugs (panitumumab and bevacizumab).

  NCT03635021· 3. fázis· Asociacion Grupo Tratamiento De Tumores Digestivos· Forrás

• Fut, nem toboroz

  Personalized Therapy Study - Attain Stability Quad Post-Approval Study

  NCT04024943· Medtronic· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Epilepszia2 toboroz
• Amiloidózis1 toboroz
• Gyomor- és nyelőcsőrák1 toboroz

Lezárt vizsgálatok

• Lezárult

  Study of Oral Atogepant Tablets to Assess Safety and Efficacy in Adult Participants With Migraine

  NCT06241313· 3. fázis· AbbVie· Forrás

• Lezárult

  A Study to Investigate Long-term Safety and Tolerability of Itepekimab in Participants With COPD

  NCT06208306· 3. fázis· Sanofi· Forrás

• Lezárult

  A Study to Evaluate Efficacy and Safety of SAR441566 in Adults With Plaque Psoriasis

  NCT06073119· 2. fázis· Sanofi· Forrás

• Lezárult

  A 32-week Trial to Evaluate the Efficacy and Safety of Tralokinumab in Subjects With Moderate-to-severe Atopic Hand Eczema Who Are Candidates for Systemic Therapy

  NCT05958407· 3. fázis· LEO Pharma· Forrás

• Toboroz

  A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)

  NCT05716100· 3. fázis· Xenon Pharmaceuticals Inc.· Forrás

• Lezárult

  Efficacy, Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of BIA 28-6156 in GBA-PD

  NCT05819359· 2. fázis· Bial R&D Investments, S.A.· Forrás

• Fut, nem toboroz

  A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE

  NCT05702034· 3. fázis· Janssen Research & Development, LLC· Forrás

• Lezárult

  A study to learn how well the study treatment asundexian works and how safe it is compared to apixaban to prevent stroke or systemic embolism in people with irregular and often rapid heartbeat (atrial fibrillation), and at risk for stroke

  NCT05643573· 3. fázis· Bayer AG· Forrás

• Lezárult

  ABTECT-1 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -1

  NCT05507203· 3. fázis· Abivax S.A.· Forrás

• Lezárult

  A Study to Assess Safety of ABBV-916 and How Intravenous ABBV-916 Moves Through Body and Affects Brain Amyloid Plaque Clearance in Adult Participants (Aged 50-90 Years) With Early Alzheimer's Disease

  NCT05291234· 2. fázis· AbbVie· Forrás

• Lezárult

  A Research Study to Look at How a New Medicine Called NNC6019-0001 Works and How Safe it is for People Who Have Heart Disease Due to Transthyretin (TTR) Amyloidosis

  NCT05442047· 2. fázis· Novo Nordisk A/S· Forrás

• Lezárult

  Epidemiological Study in FRONtoTemporal Dementia

  NCT05075187· CENTOGENE GmbH Rostock· Forrás

• Lezárult

  A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE Plus)

  NCT04777409· 3. fázis· Novo Nordisk A/S· Forrás

• Lezárult

  A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE)

  NCT04777396· 3. fázis· Novo Nordisk A/S· Forrás

• Lezárult

  Assessment of the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type

  NCT04408755· 3. fázis· Otsuka Pharmaceutical Development & Commercialization Inc.· Forrás

• Lezárult

  Study to Assess PT010 in Adult and Adolescent Participants With Inadequately Controlled Asthma (LOGOS)

  NCT04609904· 3. fázis· AstraZeneca· Forrás

• Lezárult

  CARDIO-TTRansform: A Study to Evaluate the Efficacy and Safety of Eplontersen (Formerly Known as ION-682884, IONIS-TTR-LRx and AKCEA-TTR-LRx) in Participants With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM)

  NCT04136171· 3. fázis· Ionis Pharmaceuticals, Inc.· Forrás

• Lezárult

  Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke

  NCT03872401· 3. fázis· Amgen· Forrás

• Lezárult

  Phase 3 Trial of Elacestrant Versus Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer

  NCT03778931· 3. fázis· Stemline Therapeutics, Inc.· Forrás

• Lezárult

  A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients

  NCT03626688· 3. fázis· United Therapeutics· Forrás

• Lezárult

  A Safety Extension Study of Ontamalimab in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)

  NCT03283085· 3. fázis· Shire· Forrás

• Lezárult

  Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis

  NCT02914535· 3. fázis· Alfasigma S.p.A.· Forrás

Betegségek

Betegségek, amelyekről az intézmény publikál vagy amelyekre vizsgálatot futtat.

• Fabry-betegség4 munka · 0 vizsgálat